InvestorsHub Logo
Followers 164
Posts 19773
Boards Moderated 2
Alias Born 12/09/2004

Re: Reyeton post# 452600

Saturday, 02/24/2024 1:08:26 AM

Saturday, February 24, 2024 1:08:26 AM

Post# of 462058
Australia proved the same reimbursement to Anavex that it does for other companies running drug trials in Australia. There was nothing unique about what it did for Anavex.

What Australia did was a reimbursement of a portion of the drug trial costs for running the trial in Australia. It wasn't a grant or up front funding.

Population of AU in 2023 26.6 million people.
Population of the EU is 448 million people. That is close to a 20X larger market for essentially the same amount of effort to obtain approval.

Which market would you pursue first?

Nunc est Bibendum

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News